Skyscape Web Viewer : Evidenced-Based Medicine Guidelines (EBMG) : Evidence summaries

View All
Cabergoline Versus Bromocriptine for Levodopa-Induced Complications in Parkinson's Disease
Caffeine for Asthma
Calcineurin Inhibitor Withdrawal or Tapering for Kidney Transplant Recipients
Calcitonin for Metastatic Bone Pain
Calcium Antagonists as an Add-on Therapy for Drug-Resistant Epilepsy
Calcium Antagonists for Stroke
Calcium-Channel Blockers for Raynaud's Phenomenon in Systemic Sclerosis
Calcium Intake and Bone Loss
Calcium Supplementation during Pregnancy for Preventing Hypertensive Disorders
Cancer Genetic Risk Assessment for Individuals at Risk of Familial Breast Cancer
Carbamazepine for Acute and Chronic Pain
Carbamazepine Versus Phenobarbitone Monotherapy for Epilepsy
Carbapenem Monotherapy in Intra-Abdominal Infections
Cardiac Markers in Myocarditis
Cardioselective Beta-Blockers for Chronic Obstructive Pulmonary Disease
Cabergoline for Levodopa-Induced Complications in Parkinson's Disease
Cabg Versus Ptca in Multi-Vessel Coronary Disease
Calcimimetics for Secondary Hyperparathyroidism in Chronic Kidney Disease Patients
Calcitonin for Corticosteroid-Induced Osteoporosis
Calcium and Vitamin D for Corticosteroid-Induced Osteoporosis
Calcium Antagonists for Aneurysmal Subarachnoid Haemorrhage
Calcium Channel Blockers for Inhibiting Preterm Labour
Calcium Channel Blockers Versus other Classes of Drugs for Hypertension
Calcium Supplementation (other Than for Preventing or Treating Hypertension) for Improving Pregnancy and Infant Outcomes
Calcium Supplementation for Improving Bone Mineral Density in Children
Cancer Incidence in Children Born after Assisted Reproductive Technologies
Carbamazepine for Schizophrenia
Carbamazepine Versus Phenytoin Monotherapy for Epilepsy
Cardiotocography Versus Intermittent Auscultation of Fetal Heart on Admission to Labour Ward for Assessment of Fetal Wellbeing
Cardiovascular Risk Associated with Cox-2 Inhibitors